LifeScience Cell & Gene
I Peace, Inc. Introduces HLA-Homozygous iPSC Line to Boost Compatibility and Accessibility in Allogenic Cell Therapies
I Peace, Inc., a leading GMP cell contract development and manufacturing organization (CDMO) specializing in induced pluripotent stem cells (iPSCs) and iPS...
October 30, 2024 | News
Medera Advances HFpEF Gene Therapy to High-Dose Cohort After Promising Results
Heart failure is a global pandemic with an estimated 64.3 million cases worldwide, costing over US$100B per year Heart failure with preserved ...
October 25, 2024 | News
Breaking Down Portal Fatigue in Cell and Gene Therapy: Insights from TrakCel’s Experts
In this exclusive BioPharma APAC Q&A, Dr. Matthew Lakelin, Co-Founder and Head of Consultancy Services at TrakCel, and Antonios Spanos, Industry Adviso...
October 17, 2024 | Interview
Astellas Secures Exclusive Option for AVB-101 Gene Therapy in $2.18 Billion Deal with AviadoBio
Astellas receives an exclusive option to license AVB-101, an investigational, AAV-based gene therapy in Phase 1/2 development Av...
October 11, 2024 | News
Andelyn Biosciences to Manufacture AAV for Hubble Therapeutics' Gene Therapy Targeting Rare Eye Disease
Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has been selecte...
October 11, 2024 | News
Bio-Rad Launches Vericheck ddPCR™ Kit for Precise AAV Vector Quality Assessment
Bio-Rad Laboratories, a global leader in life science research and clinical diagnostics products, announced the launch of the Vericheck ddPCR™ Empty-...
October 09, 2024 | News
Ascend Advanced Therapies Expands Gene Therapy Manufacturing with AST's GENiSYS® C Fill-Finish System
AST, a leading provider of flexible aseptic filling systems, has announced the placement of a next-generation GENiSYS® C fill-finish system&n...
October 04, 2024 | News
Minovia Therapeutics Receives FDA Clearance to Initiate Phase Ib Trial for Mitochondrial Cell Therapy in Low-Risk MDS Patients
MNV-201 is a mitochondrial cell therapy product composed of autologous hematopoietic stem cells enriched with allogeneic mitochondria In pre-clini...
September 27, 2024 | News
Belief BioMed and AskBio Forge Strategic Collaboration to Advance Liver-Targeted Gene Therapies
Belief BioMed and AskBio will work together to advance potential gene therapies in diseases with high unmet medical need, using a liver-targeted approach...
September 26, 2024 | News
CD Biopharma Receives FDA Clearance for IND Application of CD-001, Paving the Way for Phase I Clinical Trial
CD (Suzhou) Biopharma has received clearance from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application...
September 23, 2024 | News
Nona Biosciences and Umoja Biopharma Partner to Advance Next-Generation CAR-T Cell Therapies
Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to ITM), announced that it has entered into a multi...
September 13, 2024 | News
NextPoint Therapeutics Introduces NPX372, a Novel T Cell Engager Targeting B7-H7 Axis in Solid Tumors
NextPoint Therapeutics, a clinical-stage biotechnology company developing a new class of precision immuno-oncology and tumor-directed therapeutics targetin...
September 09, 2024 | News
Arsenal Biosciences Closes $325 Million Series C Funding to Advance Next-Gen CAR T-Cell Therapies for Solid Tumors
Arsenal Biosciences, Inc. (ArsenalBio), a clinical stage programmable cell therapy company focused on engineering advanced CAR T-cell therapies for solid t...
September 05, 2024 | News
Skyline Therapeutics Secures FDA Orphan Drug Designation for Gene Therapy SKG1108 to Treat Retinitis Pigmentosa
Skyline Therapeutics, an innovation-driven gene therapy company committed to developing unique and novel solutions for rare and severe diseases, announced ...
September 04, 2024 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
